跳至主要内容
临床试验/NCT01056211
NCT01056211已完成4 期

1540nm Non Ablative Fractional Laser Treatment of Scars : a Prospective Single Blinded Within Patient Controlled Randomized Trial.

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Evaluation of the adverse effect of 1540nm fractional laser versus untreated control site

研究概览

简要总结

Scars are a frequent reason of consultation in a dermatological clinic. Their cosmetic aspect can play a key role in patient satisfaction and self-image.

Non ablative fractional infra-red laser treatment is a new concept in the laser field using arrays of microscopic thermal damage patterns to stimulate a wound healing response. There are different reports on the positive effect of these type of laser treatment in the treatment of acne scarring, striae, rythides, hypopigmented and hypertrophic scars.

The low morbidity of the treatment and the lack of satisfying treatment regimes for different types of scars makes it attractive to investigate the efficacy and safety of 4 treatment with the 1540nm non ablative fractional laser in the treatment of scars.

Objectives:

  • To evaluate the efficacy of 4 laser treatments with Starlux 300 Lux 1540nm Fractional laser handpiece ( Palomar Medical Technologies ) 1 and 3 month after the last laser treatment for 3 different "scar" patient groups :
  1. Patients with hypopigmented scars
  2. Patients with hypertrophic scars
  3. Patients with scars due to grafts and reconstructions in the head and neck region.
  • To evaluate the treatment related pain. on a categorical scale from 0-10
  • To evaluate the adverse effect of 1540nm fractional laser versus untreated control in the 3 patient groups.

The study design is a prospective single blinded randomised within-patient controlled study The study involves 6 visits.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Evaluation of the adverse effect of 1540nm fractional laser versus untreated control site

时间窗: at 1 and 3 months

efficacy of 4 laser treatments with Starlux 300 Lux 1540nm Fractional handpiece (Palomar Medical Technologies) 1 and 3 months after the last laser treatment in 3 different "scar" patient groups

时间窗: at 1 and 3 months

Evaluation of the treatment related pain

时间窗: at 1 and 3 months

次要结局

  • Compare different clinical scar assessment tools that can be used in the evaluation of clinical efficacy of the laser treatment(at 1 and 3 months after treatment)
  • Physician assessment for the treated and control region (PhGA)(at 1 and 3 months after treatment)
  • patient assessment for the treated and control region(at 1 and 3 months after treatment)
  • Evaluation of skin redness and pigmentation(at 1 and 3 months after treatment)
  • Evaluation of histological difference in treated an non treated parts of the scar(at 3 months after treatment)
  • Photografic documentation of scar improvement(at 1 and 3 months after treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验